SEGMENTS (Tables)

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the years ended December 31, 2021 and 2020: 

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended December 31, 2021
Revenue	$	14,213,379		$	-		$	5,543,066		$	42,377		$	19,798,822
Cost of Sales		(11,073,756	)		-			(214,019	)		(14,039	)		(11,301,814	)
Gross Margin		3,139,623			-			5,329,047			28,338			8,497,008
Operating Expenses		(1,136,031	)		(183,429	)		(3,624,200	)		(18,547,470	)		(23,491,130	)
Operating Income (Loss)		2,003,592			(183,429	)		1,704,847			(18,519,132	)		(14,994,122	)
Other Income (Expense)		(8,955	)		1,286,962			(39,265,445	)		(65,502,017	)		(103,489,455	)
Net Income (Loss) Before Income Tax		1,994,637			1,103,533			(37,560,598	)		(84,021,149	)		(118,483,577	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended December 31, 2020 (As Restated)
Revenue	$	13,643,689		$	-		$	2,594,511		$	-		$	16,238,200
Cost of Sales		(11,779,984	)		-			(305,590	)		-			(12,085,574	)
Gross Margin		1,863,705			-			2,288,921			-			4,152,626
Operating Expenses		(660,647	)		(54,673	)		(1,545,244	)		(4,076,800	)		(6,337,364	)
Operating Income (Loss)		1,203,058			(54,673	)		743,677			(4,076,800	)		(2,184,738	)
Other Income (Expense)		1,983			(77	)		(1,392,617	)		(1,098,888	)		(2,489,599	)
Net Income (Loss) Before Income Tax		1,205,041			(54,750	)		(648,940	)		(5,175,688	)		(4,674,337	)
December 31, 2021
Cash and Restricted Cash	$	7,493,921		$	245,780		$	2,629,464		$	50,433,014		$	60,802,179
Total Assets		55,465,600			2,199,466			11,056,779			115,488,298			184,210,143
December 31, 2020
Cash and Restricted Cash	$	8,150,769		$	158,058		$	1,590,265		$	21,836,387		$	31,735,479
Total Assets		28,954,484			158,160			524,603			78,076,498			107,713,745